With the government expected to come out with a new Drug Price Control Order this month, revenues of top pharma companies are likely to take a hit. Tying up all the loose ends of National Pharmaceutical Pricing Policy 2012, the government intends to fix the price for 348 'life saving' drugs on the basis of a simple average of the current market prices of all drug brands meant for the treatment of a particular disease. The policy is expected to lower the buying cost of several medicines by 50 to 70 per cent, and could also reduce profitabili